title: Defining the new end point for multiple sclerosis treatment.
authors.affiliation: Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Stangel
authors.affiliation: Cognitive Psychology and Methodology, Basel University, Basel, Switzerland.
authors.forename: Iris-Katharina
authors.initials: IK
authors.lastname: Penner
authors.affiliation: Department of Neurology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
authors.forename: Bernd C
authors.initials: BC
authors.lastname: Kieseier
mesh_terms: D018450:Disease Progression; D006801:Humans; D009103:Multiple Sclerosis / Q000628:therapy*; D016896:Treatment Outcome